The increase in these mediators in the blood is associated with increased activity of 5–LOX, 12–LOX, and 15–LOX in patients with chronic lymphocytic thyroiditis and may indicate the involvement of the above–mentioned pathways in the pathogenesis of the disease. This evidence concerns the gene SPRR2A and Hashimoto thyroiditis.